MicroRNA test could spot hidden virus in transplant patients
NCT ID NCT07181330
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 34 times
Summary
This study tested a new blood test that looks for a tiny piece of genetic material from the cytomegalovirus (CMV) in patients who had a stem cell transplant. Researchers used stored blood samples from 60 patients to see if the test could detect CMV reactivation as well as the standard DNA test. If proven accurate, this test might help doctors catch and treat CMV infections earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350001, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SE-SPTM-PCR microRNA assay (a blood test)
What this could lead to
If successful, this test could provide a faster or more accurate way to detect CMV infection in stem cell transplant patients, helping doctors treat it earlier.
What could go wrong
This is a small, retrospective study using stored samples, not a real-time test. The new test may not prove better than current methods, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.